• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • PDF single page
  • PDF page with subpages
  • PDF page with linked pages
  • DOCX single page
  • DOCX page with subpages
  • Export to PDF
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Critical appraisal:Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al 2010 5

From Cancer Guidelines Wiki
Jump to:navigation, search
Jutta's exclamation mark icon.png This appraisal is pending.


Article
Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010 Nov 20;376(9754):1741-50 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20970847.
Assigned to
User:Priyashiel.parikh
Topic area
Guidelines:Colorectal cancer/Prevention
Clinical question
  • PPR1: What is the risk-benefit ratio for use of aspirin for prevention of colorectal cancer stratified by risk of colorectal cancer itself? (What is the optimal dose and frequency of administration?)
Form
Form:Quality appraisal sr
Outcomes
CRC incidence

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Critical_appraisal:Rothwell_PM,_Wilson_M,_Elwin_CE,_Norrving_B,_Algra_A,_Warlow_CP,_et_al_2010_5&oldid=120672"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.